The article provides an overview of analyst ratings for NextGen Healthcare (NASDAQ:NXGN) over the past 3 months. The average 12-month price target has decreased by 6.53% from the previous average, indicating a neutral short-term impact on the stock price. The relevance and importance are high as the information directly pertains to the company's stock price and investor sentiment.